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Abstract Adipose derived mesenchymal stromal/
stem cells (ASCs) are a heterogeneous population
characterized by (a) their ability to adhere to plastic;
(b) immunophenotypic expression of certain cell
surface markers, while lacking others; and (c) the
capacity to differentiate into lineages of mesodermal
origin including osteocytes, chondrocytes and adipo-
cytes. The long-term goal is to utilize these cells for
clinical translation into cell-based therapies. However,
preclinical safety and efficacy need to be demonstrated
in animal models. ASCs can also be utilized as
biological vehicles for vector-based gene delivery
systems, since they are believed to home to sites of
inflammation and infection in vivo. These factors
motivated the development of a labelling system for
ASCs using lentiviral vector-based green fluorescent
protein (GFP) transduction. Human ASCs were trans-
duced with GFP-expressing lentiviral vectors. A
titration study determined the viral titer required to
transduce the maximum number of ASCs. The effect
of the transduced GFP lentiviral vector on ASC
immunophenotypic expression of surface markers as
well as their ability to differentiate into osteocytes and
adipocytes were assessed in vitro. A transduction
efficiency in ASC cultures of approximately 80 %was
observed with an MOI of *118. No significant
immunophenotypic differences were observed
between transduced and non-transduced cells and
both cell types successfully differentiated into adipo-
cytes and osteocytes in vitro. We obtained [80 %
transduction of ASCs using GFP lentiviral vectors.
Transduced ASCs maintained plastic adherence,
demonstrated ASC immunophenotype and the ability
to differentiate into cells of the mesodermal lineage.
This GFP-ASC transduction technique offers a poten-
tial tracking system for future pre-clinical studies.
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pen/strep Penicillin and streptomycin
FBS Fetal bovine serum
a-MEM Alpha-Modified Eagle Medium
GlutaMAXTM
DMEM Dulbecco’s Modified Eagle Medium
PBS Phosphate buffer saline




MOI Multiplicity of infection
TU/ll Transducing units per microliter
ddH2O Double distilled water
STD DEV Standard deviation
Introduction
Adipose derived mesenchymal stromal/stem cells
(ASCs) are a heterogeneous cell population charac-
terized (a) by their ability to adhere to plastic; (b) the
immunophenotypic expression of certain cell surface
markers (CD73, CD90, CD105) while lacking others
(CD34, CD45); and (c) the capacity to differentiate
into cells of mesodermal origin including osteocytes,
chondrocytes and adipocytes (Bunnell et al. 2008;
Dominici et al. 2006; Pittenger et al. 1999). This
makes ASCs an attractive option for tissue engineer-
ing and regenerative medicine. Pre-clinical studies
using experimental animal models to establish safety
and efficacy are an essential requirement before ASCs
can confidently be assessed as cellular therapy prod-
ucts in clinical trials. However, the unavailability of
efficient and reliable methods of tracking and moni-
toring ASCs in vivo constitutes a significant obstacle.
Green fluorescent protein (GFP) has previously
been used to evaluate living cells in situ (Kafri et al.
1997; Miyoshi et al. 1997; Naldini et al. 1996; Tao
et al. 2014) as it emits fluorescence that can be
detected by most microscopy as well as flow cytom-
etry systems. For this reason it is also an attractive
marker for in vivo tracking of stem cells in animal
models. It is however immunogenic which may
compromise the interpretation of results (Yang et al.
2014).
Lentiviral vectors are gene delivery tools which
have the ability to integrate genetic cargo into the
chromosomes of a target cell. This allows for the
delivery of most forms of genetic material while
minimizing the risk of the vector-transduced cells
being attacked by virus-specific cytotoxic T-lympho-
cytes. This is accomplished by not transferring
sequences encoding for proteins required for packag-
ing the virus (Naldini et al. 1996; Barde et al. 2010).
ASCs can be utilized as biological vehicles for
vector-based gene delivery systems, since they are
believed to home to sites of inflammation and infection
in vivo (Karp et al. 2009; Sordi et al. 2005). The
approach to lentiviral transduction optimization for
gene therapy applications must be distinguished from
transduction efficacy used to produce an efficient
tracking system. Integration of the lentiviral genomic
material into the target cell genome is dependent on
lentiviral integrase, the key determinant for gene-
targeted integration specificity (Lewinski et al. 2006).
Human immunodeficiency virus type-1 (HIV-1)-based
lentiviral vectorsmediate efficient gene transfer to both
proliferating and quiescent cells, although transgene
insertion into the DNA of target cells is biased toward
transcriptionally active loci, increasing the risk of
insertional mutagenesis (Staunstrup et al. 2009).
Although the integration of one lentiviral genome
copy per target cellwould be ideal for the application of
gene therapy, thereby decreasing the risk of mutage-
nesis, multiple copies per target cell would be prefer-
able for tracking purposes. The presence of multiple
copies per cell results in strong GFP expression and
consequently a high fluorescence signal which would
make tracking easier andmore efficient. However, care
should be taken that insertion of multiple GFP copies
per cell does not change the basic characteristics of the
cell and result in cell transformation.
The aim of this study was to optimize GFP
transduction efficiency of human ASCs using lentivi-
ral vectors and to evaluate the effect of transduction on




Approval was obtained from the Research Ethics
Committee of the Faculty of Health Sciences, Univer-
sity of Pretoria (protocol number 218/2010). Written
informed consent was obtained prior to lipoaspirate
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harvesting from healthy donors undergoing routine
plastic or reconstructive surgery procedures.
Isolation, characterization and expansion of ASCs
HumanASCswere isolated from lipoaspirate, andwere
characterized and expanded according to protocols
described by Zuk (2001) and Bunnell et al. (2008; Zuk
2001). In short, lipoaspirate was washed three times
with phosphate-buffered saline (PBS) to remove con-
taminating peripheral blood cells, after which the
sample was subjected to enzymatic digestion to sepa-
rate the stromal vascular fraction (SVF) from mature
adipocytes. The red blood cells were lysed and the cell
suspension strained through a 70 lm cell strainer
(Millipore, Billerica, MA, USA) before seeding the
SVF into culture flasks at a density of 5.0 9 105 cells/
cm2. After 24 h the non-adherent cells were removed
resulting in selection for the adherent cell component
present in the adipose derived SVF. ASC cultures were
maintained under standard culture conditions (37 C,
5 % CO2) in alpha-Modified Eagle Medium Glu-
taMaxTM culture medium (a-MEM, Gibco, Life Tech-
nologies/Thermo Fischer Scientific, Carlsbad, CA,
USA) supplemented with 10 % fetal bovine serum
(FBS) and 1 % penicillin and streptomycin (pen/strep,
Gibco).At 80 %confluence, the cultureswerepassaged
using0.25 %Trypsin/EDTA(Gibco) and re-seeded at a
density of 5.0 9 103 cells/cm2.
Preparation of GFP encoding lentiviral vectors
The three plasmids used for lentiviral vector produc-
tion were psPAX2 (envelope function), pMD2G
(packaging function) and pLVTH (transfer function).
The pLVTH plasmid is a self-inactivating vector
(SIN) using an EF1a promotor to drive GFP expres-
sion (Wiznerowicz and Trono 2003).
Vector stock was obtained through heat shock
transformation of DH5a bacteria and subsequent
extraction from the cells using a Zyppy plasmid
Maxiprep Kit (Zymo Research Corporation, Irvine,
CA, USA). The extracted plasmids were concentrated
to 1 lg/ll and stored at -20 C.
Plasmidswere co-transfected into the human embry-
onic kidney 293T cell line (HEK293T cells; NIHAIDS
Reagent Program, Germantown,MD, USA) to produce
lentiviruses that are capable of transducing the GFP
gene as previously described by Barde et al. (2010).
Three culture dishes (100 mm diameter) were
seeded with HEK 293T cells at 1–3 million cells per
dish in 10 ml Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10 % FBS and 1 % pen/
strep. Plasmid DNA concentrations were 1 lg/ll, and
the amounts used for transfecting 293T cells were 3 ll
pMD2G, 8 ll psPAX2 and 10 ll pLVTH, respec-
tively. The plasmids were resuspended in double
distilled water (ddH2O) containing 2.5 mMHepes and
250 ll of a 0.5 M CaCl2 solution. One millilitre of the
mixture was added to the pre-prepared HEK 293T cell
culture dishes followed by incubation for 12 h under
standard culture conditions. After 12 h the condi-
tioned medium was aspirated, followed by a washing
step with PBS supplemented with 1 % pen/strep after
which 15 ml DMEM was added to the culture. The
cultures were incubated for an additional 24 h under
standard culture conditions.
The conditioned medium (supernatant; 15 ml)
containing the lentiviral stock was harvested from
the cultures. The first harvest pool was placed into
50 ml tubes and stored at 4 C. The harvesting
procedure was repeated twice. The pooled supernatant
was then centrifuged for 10 min at 1153g to produce a
pellet consisting of cells and debris. The cell-free
supernatant was subjected to ultra-centrifugation for
120 min (16 C) at 49,460g after which the super-
natant was discarded and the pellet re-suspended in
80 ll Hank’s Balanced Salt Solution without Ca2
?-
Mg2
? (HBS). The vector stock/HBS solution was
vortexed gently every 30 min while being incubated at
room temperature for 2 h. The vector stock solutions
from three transfection procedures were pooled to
produce a homogenous vector stock solution and
stored at -80 C. Freezing and thawing of the
lentiviral stock were avoided as far as possible.
Optimization of ASC transduction by the GFP
encoding lentiviral vectors
For tracking purposes, a titration study was performed
to establish a linear regression standard curve as well as
the optimal titer that would lead to the maximum
number of cells in the ASC population expressing GFP
(Supplementary Figure 1). ASCs were seeded into two
6-well plates at a density of 5 9 103 cells per cm2 and
incubated for 12 h under standard culture conditions.
Varying amounts of vector stock were added to the
wells containing adherent ASCs in 2 ml DMEM
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supplemented with 1 % pen/strep and 10 % FBS
(Table 1). The control (non-transduced) wells received
250 ll sterile PBS. The plates were maintained under
standard culture conditions, and the DMEM plus 1 %
pen/strep and 10 % FBS was replaced every 48 h until
80–90 % confluence was reached. The cultures were
passaged by trypsinization using 0.25 % Trypsin/
EDTA (Gibco). Enzymatic activity was halted after
20 min through the addition of 2 ml DMEM plus 1 %
pen/strep and 10 % FBS and the cell suspension
centrifuged at 265g for 5 min at 21 C. The pellet
was re-suspended in 1 ml PBS plus 2 % pen/strep and a
100 ll aliquot was used for GFP expression analysis
using flow cytometry (Gallios, Beckman Coulter,
Miami, FL, USA). The remaining cell suspension was
re-seeded into culture at a density of 5 9 103 cells/cm2.
The number of cells expressing GFP was measured for
all the respective titration cultures over 10 passages.
TheD’Agostino& Pearson omnibus normality test was
used to assess for a Gaussian distribution over the 10
passages at the various exposure concentrations.
ASC transduction with GFP encoding lentiviral
vectors
ASC cultures from three different individual donors
were characterized according to the criteria set out by
Dominici et al. (2006) before they were considered for
the transduction experiments. The three cultures at
passages 8, 11 and 14 were each seeded separately into
2 wells of a 6-well plate containing 2 ml DMEM plus
1 % pen/strep and 10 % FBS at a seeding density of
5 9 103 cells/cm2, and incubated for 12 h under
standard culture conditions. The titration experiment
demonstrated transduction of [74 % of the ASC
population based on mean GFP expression. This was
maintained over 10 consecutive passages post trans-
duction. 250 ll of viral stock solution resulted in a
titer of 22,594 transducing units (TU)/ll and an MOI
*118. The control wells (non-transduced) from the
same individual ASC culture received 250 ll of PBS.
The cultures were maintained under standard culture
conditions and DMEM plus 1 % pen/strep and 10 %
FBS was replaced every 48 h. The non-transduced and
the transduced cells were treated in exactly the same
way for all purposes and for each individual ASC
culture, and were maintained under similar conditions
and passaged at the same time.
Evaluation of transduction efficacy
and immunophenotype using flow cytometry
The transduced and non-transduced cells from an
individual ASC culture were trypsinized and re-
suspended in PBS. A 100 ll aliquot from both cell
suspensions was simultaneously stained with a panel
of monoclonal mouse anti-human antibodies (CD34,
CD45, CD73, CD90 and CD105; Beckman Coulter,
Miami, FL, USA). Another 100 ll from the non-
transduced cell suspension was used as the unstained
immunophenotypic control (GFP negative control).
The cell suspensions were incubated in the dark at
room temperature for 10 min before washing three
times with PBS supplemented with 10 %FBS and 1 %
pen/strep. The GFP positive population was detected
in the FL1 channel (emission spectrum; 525/40 nm)
and the GFP positive ASC population was calculated
as a percentage of viable ASCs. Cell populations were
immunophenotypically characterized by determining
the expression or lack of expression of respective cell
surface markers on a single cell basis.
Lineage induction and qualitative capacity
assessment of transduced and non-transduced
ASCs
Both the transduced and non-transduced cultures
were induced to differentiate into adipogenic and
Table 1 Volume of vector stock added to 48,000 ASCs see-
ded 12 h prior to transduction, with the mean percentage cells
expressing GFP across 10 post-transduction passages and
respective MOIs





0 ll (150 ll PBS) 0.90 0
0 ll 0.61 0
5 ll 2.71 2
25 ll 8.41 12
50 ll 5.25 24
100 ll 11.32 47
150 ll 56.93 71
200 ll 56.20 94
250 ll 74.85 118
300 ll 75.73 141
a ASCs were from biological replicate no 1. These data were
however only for titration purposes only
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osteogenic lineages. The adipogenic and osteogenic
induction protocols were adapted from methods
described previously by Zuk et al. (2002) and Zuk
(2001). Oil Red O was used to qualitatively assess the
adipocyte differentiation capacity by visualizing lipid
droplets in mature adipocytes. Osteogenic differenti-
ation was qualitatively assessed using 2 % Alizarin
Red S which detects calcium deposition from mature
osteocytes. Images were captured using a Zeiss Axio
Vert200 fluorescence microscope (Mu¨nchen, Ger-
many) equipped with a Zeiss Axiocam MRc5 digital
camera (Mu¨nchen, Germany; Fig. 3).
Evaluation of GFP expression after differentiation
Adipogenic-, osteogenic- and non-induced cultures
were fixed on days 7, 14 and 21 after induction. During
the assessment of transduced adipogenic and osteo-
genic cultures, 40,6-diamidino-2-phenylindole (DAPI;
0.02 lg/ml) staining was performed. Images were
captured using a Zeiss Axio Vert200 microscope
equipped with a Zeiss Axiocam MRc5 digital camera,
utilizing blue (Excitation G 365; Emission BP 445/50)
and green (Excitation BP 450-490; Emission LP 515)
filter sets to detect DAPI and GFP, respectively.
These photographs were then superimposed on one
another using Photoshop Light Room software
(photoshop.com).
Statistical analysis
Non-transduced (control) cells, transduced cells not
expressing GFP and transduced cells expressing GFP
were assessed with regard to immunophenotype. The
means for each replicate were compared using One
Way Analysis of Variance across all three groups. The
Student’s T test was used to compare the means of the
transduced cultures expressing GFP and those not
expressing GFP with the control non-transduced cells,
and a P value of \0.05 was considered to be
significant.
Results
Human ASCs were isolated, characterized and
expanded to be used for further experiments. All the
ASC cultures adhered to the Dominici and co-workers
proposed criteria with regard to adherence to plastic,
[95 % cell surface expression of CD73, CD90 and
CD105, \5 % expression of CD34 and CD45 and
differentiation into adipose and osteogenic lineages
(Dominici et al. 2006).
A titration study was performed to determine the
optimal titer required to transduce the maximum
number of ASCs. The vector stock solution contained
22,954 virion particles per microlitre. Low levels of
GFP expression were observed across all passages
using low volumes (5–100 ll) of viral stock solution.
The transduction efficiency improved to more than
50 %GFP expression when the ASCs were exposed to
150 ll (*340,000 virion particles) of the vector stock
solution and an optimal transduction efficiency was
achieved using 250–300 ll of the vector stock solu-
tion. Little difference was observed across 10 post
transduction passages with regard to the percentage of
GFP expressing cells within the population, when
using between 250 and 300 ll of viral stock solution
(Table 1). Data at all passages, with the exception of
T0 and T3 fitted a Gaussian distribution and the
coefficient of determination as determined using the
two-tailed Pearson correlation was significant
(R2 = 0.92, P\ 0.0001). The interpolated values
were as follows: 100 % transduction = 363.18 ll;
90 % transduction = 326.86 ll; 80 % transduc-
tion = 290.54 ll; 70 % transduction = 254.23 ll
(Supplementary Figure 1).
Transduction of three biological replicates (i.e. cells
from different donors) was performed using 250 ll
lentiviral stock solution with a titer of 22,594 TU/ll
and an MOI of *118. The percentage of ASCs
expressing GFP was monitored across 12 consecutive
passages (Fig. 1). A stable percentage of GFP express-
ing cells was observed [mean: 81 %; standard deviation
(STD DEV): 4.04] within the transduced cultures over
12 post-transduction passages.
Fluorescence (expression) intensity was assessed
using flow cytometry and microscopic imaging at
post-transduction passages (T). Sustained GFP expres-
sion intensity was observed across 14 post-transduc-
tion passages. Visual images at T2, T8 and T14
showed little difference in fluorescence intensity
(Fig. 2a–c), while flow cytometry results quantita-
tively measured a slight increase in fluorescence
Cytotechnology (2016) 68:2049–2060 2053
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intensity with increasing passages (Fig. 2d; One
outlier at T5 was removed from the analysis). Little
difference was observed when comparing the mean
proliferation of non-transduced and transduced ASCs
across 10 passages T1–T10 (Fig. 3). Every biological
replicate had a non-transduced as well as a transduced
culture that was seeded and harvested on the same day
at 70–80 % confluency. The number of cells harvested
at every passage is expressed as cell density (cells/
cm2). The number of days between passages increased
with increasing passages, suggesting a decrease in
proliferation capacity with increasing passage
number.
The cells were analyzed on a Gallios flow cytome-
ter using a multiparameter approach. Cells were
simultaneously stained with CD105 PE (FL 2),
CD90 PC5 (FL 4), CD34 PC7 (FL5), CD73 BV510
(FL9) and CD45 KO (FL10). GFP (FL 1) expression
was also assessed. Colour compensation was set
according to single colour staining tubes and appro-
priate Fluorescence-Minus-One (FMO) control tubes
were used to ensure optimal colour compensation and
region of interest settings. We observed that non-
transduced and transduced cultures displayed similar
phenotype profiles, when the co-expression of the
markers was considered. However, sub-dividing the
transduced culture into GFP positive cells (success-
fully transduced) and GFP negative cells (not
successfully transduced), showed a trend towards a
decrease, although not significant, in the immunophe-
notypic co-expression within the GFP positive trans-
duced cells (Table 2).
In order to establish if specific markers are
responsible for the observed change in the co-
expression profile of the GFP positive cells, the
expression of individual markers was also investi-
gated (Fig. 4). The individual marker expression
profiles of three biological replicates is shown
individually as (a), (b) and (c) over four consecutive
post-transduction passages, namely T2–T5, T8–T11
and T16–T19 for biological replicates 1, 2, and 3,
respectively (Fig. 4). Thus the biological replicates
were assessed at the same post-transduction pas-
sages. Similarities were observed with regard to the
expression profiles of the individual markers between
the non-transduced and transduced cultures at respec-
tive post transduction passages. We did however
observe a decrease in CD105 in biological replicates
2 and, in particular, 3 with increasing passages, as
well as varying levels of expression of CD34 and
CD45 (no consistent pattern) in all non-transduced
and transduced cultures. The trend in replicates 1 and
2 was a decrease in non-ASC markers, while the
outstanding trend in replicate 3 was an increase in
CD45. The reasons or these differences are not
known. In view of the increase in CD45 in replicate 3,
Fig. 1 Percentage of ASCs
expressing GFP. ASCs were
transduced with a GFP-
expressing lentiviral vector,
and GFP expression was
determined by flow
cytometry. Data from three
biological replicates over 12
consecutive passages post
transduction are presented.
Values represent mean %
GFP positive ASCs
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we would choose not to use these cells for tracking
purposes.
Non-transduced and transduced cells of the three
individual cultures were induced to differentiate into
adipogenic and osteogenic lineages in vitro. The
lineages were confirmed using Oil Red O to indicate
the presence of intracellular lipid droplets during
adipogenic differentiation and Alizarin Red S to detect
calcium deposits following osteogenic differentiation
(Figs. 5, 6).
From the DAPI stained images it was clear that
the cells were ‘‘over populated’’, especially with
regard to the transduced, non-induced controls and
the osteogenic induced cultures. The GFP images for
these respective cultures showed overlaying bright
expression making it difficult to locate individual
cells. Individual GFP positive cells could be
observed in the transduced, adipogenic induced
cultures (Fig. 5).
Both non-transduced and transduced cultures were
able to differentiate into adipocytes as visualized by
Oil Red O stained intracellular lipid droplets and also
into osteogenic tissue as evidenced by the presence of
Alizarin Red S stained calcium deposits (Fig. 6). It
was noticed that the density of adherent cells
decreased considerably during adipogenic induction;
this was observed in both non-transduced and trans-
duced cultures.
Discussion
This study shows successful transduction of human
ASCs with a lentiviral vector encoding GFP for
potential use as a tracking system in future in vivo
studies. Our results also show sustained expression of
GFP during extensive expansion ([10 passages), as
well as adipogenic and osteogenic differentiation
in vitro.
The titration study showed stable expression of
GFP following transduction with 250 ll of virus stock
solution, which translates to a titer of 22,594 TU/ll
and an MOI of*118. The process of preparing GFP
positive lentiviral stock is time consuming and
expensive and it is therefore important to consider
using smaller volumes of the virus stock solution for
transduction. However, according to our findings, a
virion to cell ratio of less than 25:1 would not result in
Fig. 2 GFP expression intensity across post-transduction pas-
sages. aASC culture at post-transduction passage 2 (T2); bASC
culture at T8; and c ASC culture T14. a–c are from the same
biological replicate (donor). d Stable GFP expression intensity
(X-GMean) was observed across eight post-transduction pas-
sages (T) using flow cytometry. A slight increase in GFP
expression intensity can be observed with increasing post-
transduction passages. Values are mean ± STD DEV from
three pooled donor cultures
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optimal transfection and is therefore likely to result in
suboptimal assessment of the homing abilities/trans-
plant efficiency of the transduced cells, as a large
portion of the transplanted cells would not be able to
be tracked. This problem could be overcome by
selection for GFP-positive cells using fluorescent-
activated cell sorting (FACS) prior to in vivo
transplantation.
Fig. 3 Proliferation of non-
transduced and transduced
ASCs across passages T1–
T10. For every biological
replicate a non-transduced
as well as a transduced
culture was seeded and
harvested on the same day at
70–80 % confluency. The
left axis represents the
density of cells harvested
and is shown as cells/cm2.
The right axis indicates the
mean number of days the
cultures were left to expand
from seeding to harvesting
at 70–80 % confluency.
Values are mean ± STD
DEV







CD34 -, CD45 -, CD73 ?, CD90 ?, CD105 ? immunophenotype
across 4 passagesb
P value comparison






















1 77 23 93.70 4.88 91.31 5.50 0.28 86.51 6.15 0.082 0.34
2 81 19 76.00 19.88 66.08 27.75 0.30 55.02 18.41 0.11 0.55
3 86 14 67.75 24.85 64.93 31.34 0.45 40.1 35.84 0.15 0.66
Mean 81 19 79.15 13.261 74.10 14.91 0.35 60.54 23.69 0.18 0.5
a Mean % GFP positive and negative cells across 12 passages
b Values represent mean ± STD DEV of ASCs expressing the CD34 -, CD45 -, CD73 ?, CD90 ?, CD105 ?
immunophenotype across four passages: T2-T5 for replicate 1; T8-T11 for replicate 2; T16-T19 for replicate 3
c P values were determined by a three way comparison between non-transduced, transduced GFP negative and transduced GFP
positive cultures
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Although more than 70 % of the cells expressed
GFP at all time-points, the expression varied among
the three biological replicates (donors), one being
consistently more than 80 % and the other showing
increased expression from passage eight onwards,
making this marker a suitable candidate for future
expansion experiments. The difference in GFP expres-
sion observed between different biological replicates
could be due to inter-patient variability.
All the transduced and non-transduced cultures
differentiated successfully into adipogenic and osteo-
genic lineages. Overlaying DAPI stained and GFP
images served as a quality control for GFP expres-
sion. All cells within the adipogenic induced cultures
demonstrated GFP expression. Interestingly, the
adipogenic induced cells did not expand to conflu-
ency compared to the osteogenic induced cells, and
this seems to be a consistent finding. Possible reasons
include: (a) initial cell death during induction due to
toxicity of the induction medium; (b) the nature of
adipocytes which are ‘‘contact inhibited’’ and require
a specific surface area to expand; or (c) only a
specific sub-population within the heterogeneous
population has the ability to differentiate into the
adipogenic lineage, although the findings are consis-
tent for both transduced and non-transduced cultures.
Also, from the overlaid images, one can observe
matrix formation (blurry effect in fluorescent images)
of the osteogenic induced cultures which were also
GFP positive.
An important finding is that we did not observe a
decrease in GFP expression during the differentiation
process. This is important when considering using this
marker to investigate homing and site-specific differ-
entiation of ASCs in pre-clinical applications in
animal models. Similar findings of GFP expression
stability in umbilical cord derived MSCs were
reported by Tao et al. (2014) confirming that lentiviral
vector mediated GFP expression provides a stable,
efficient labeling model in comparison to other
tracking models including 5-bromo-2-deoxyuridine
(BrdU) and DAPI. Models utilizing BrdU and DAPI
present with a number of disadvantages such as
quenching during cell division as well as quenching
over long time frames. In addition, GFP lentiviral
vector labeling does not require expensive reagents
and detection equipment as does Y chromosomal
labeling and magnetic tagging (Tao et al. 2014).
We were able to obtain more than 80 %
lentiviral transduction efficiency of ASCs. No
significant changes in proliferation capacity or in
Fig. 4 Expression profile of individual markers in transduced
ASCs from three biological replicates (donors). Expression of
cell surface markers CD 105 PE (FL 2), CD 90 PC5 (FL 4), CD
34 PC7 (FL5), CD73 BV510 (FL9) and CD45 KO (FL10) was
detected by flow cytometry. GFP (FL 1) is indicated as a
percentage of the gated ASC population. The individual marker
expression profiles are shown individually as a–c over four
consecutive post-transduction passages namely T2–T5, T8–T11
and T16–T19 for three biological replicates, respectively. Every
biological replicate had one GFP lentiviral vector transduced
culture (represented by T on x-axis) and one non-transduced
culture (represented by N - t on x-axis) that were processed
similarly. Cells were seeded at a density of 5000 cells/cm2 and
were harvested on the same day at 70–80 % sub-confluency
Cytotechnology (2016) 68:2049–2060 2057
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cell surface marker expression were observed
between transduced and non-transduced cultures,
although in one biological replicate (no. 3) there
was an increase in CD45 with increasing passage
number. The reasons for this increase are not know,
but we would exclude these cells from further use
for tracking purposes. Transduced cells like non-
transduced cells demonstrated similar morphology
and differentiation.
The percentage GFP positive cells seem to decrease
slightly during passages 1 and 5, suggesting a transi-
tion phase, followed by a steady increase thereafter.
The level of GFP expression in individual cells did not
decrease with time, demonstrating persistent intracel-
lular GFP protein production. These optimized GFP
positive lentiviral vector transduction procedures and
our results obtained therefrom demonstrate that the
standardized criteria used for defining human ASCs
were not compromised. Future research will be
directed at ASC tracking to study homing, migration,
engraftment and in situ differentiation, all of which are
relevant to organ regeneration and restoration. To use
this ASC lentiviral transduction technique for gene
delivery applications, further transduction optimiza-
tion will be needed to obtain a minimal number of
copies per transduced cell.
Fig. 5 Fluorescence microscopy analysis of adipogenic and
osteogenic differentiation in non-transduced and transduced
cultures. a Non-transduced, non-induced ASCs, stained with
DAPI. b Transduced, non-induced ASCs, stained with DAPI.
c Transduced, non-induced ASCs, with a GFP positive
cytoplasm. d Transduced, non-induced ASCs, with overlay of
the DAPI stained and GFP expression images (different vision
field than b and c). eNon-transduced, adipogenic induced ASCs,
stained with DAPI. f Transduced, adipogenic induced ASCs,
stained with DAPI. g Transduced, adipogenic induced, GFP
positive cytoplasm. h Transduced, adipogenic induced ASCs,
with overlay of the DAPI stained and GFP positive expression
images (different vision field than f and g). i Non-transduced,
osteogenic induced ASCs, stained with DAPI. j Transduced,
osteogenic induced ASCs, stained with DAPI. k Transduced,
osteogenic induced ASCs, GFP positive cytoplasm. l Trans-
duced, osteogenic induced ASCs, with overlay image of DAPI
stained and GFP positive expression images (different vision
field than j and k). These representative images are of the day 21
post-induction time point
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